CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale VP, Finance and CAO sold 482 shares at $11.07 ($5,336)
- 4 Open-market sale Chief Medical Officer sold 1,617 shares at $11.07 ($17,901)
- 4 Open-market sale Chief Financial Officer sold 893 shares at $11.07 ($9,886)
- 4 Open-market sale President & CEO sold 3,232 shares at $11.07 ($35,779)
- 4 Option exercise Chief Medical Officer acquired 46,474 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 37,000 shares (grant or award)
- 4 Grant or award VP, Finance and CAO acquired 11,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 29,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 74,000 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
Page 13 of 22 · 421 filings